相关实验视频
Updated: Jul 7, 2026

Murine Prostate Micro-dissection and Surgical Castration
Published on: May 11, 2016
DSCAM-AS1促进前列腺癌的发展
Lin Cheng1, Shuhui Li2, Deqi Jiang1
1Department of Urology Surgery, Shandong Provincial Third Hospital, No. 12, Wuyingshan Middle Road, Tianqiao District, Jinan, 250031, Shandong, China.
长非编码RNA DSCAM-AS1在前列腺癌中升高,表明预后不佳. 通过向miR-338-3p,它的敲击抑制了癌症的进展,提供了潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因规则 基因规则
背景情况:
- 前列腺癌仍然是一个重大的全球健康问题.
- 识别新的分子点对于推进治疗策略至关重要.
- 长非编码RNAs (lncRNAs) 越来越多地被认为是它们在癌症发展中的作用.
研究的目的:
- 为了研究 lncRNA DSCAM-AS1 在前列腺癌中的作用.
- 探索DSCAM-AS1作为一个潜在的治疗目标.
- 阐明涉及前列腺癌中DSCAM-AS1和miR-338-3p的调节机制.
主要方法:
- 定量实时PCR (RT-qPCR) 用于评估DSCAM-AS1表达.
- 卡普兰-梅尔曲线和奇方测试用于临床和预后评估.
- 双 luciferase 记者测定用于确定 DSCAM-AS1 和 miR-338-3p 之间的相互作用.
- 细胞增殖 (CCK-8) 和转移 (Transwell) 测试以评估功能性作用.
主要成果:
- 发现DSCAM-AS1在前列腺癌组织和细胞系中被上调.
- 在前列腺癌患者中,增加的DSCAM-AS1表达与不良预后相关.
- 击败DSCAM-AS1抑制了前列腺癌细胞的增殖和转移.
- miR-338-3p被确定为DSCAM-AS1的直接标,并且在前列腺癌中被下调.
- 沉默DSCAM-AS1抑制了癌症的进展,这被miR-338-3p knockdown扭转.
结论:
- 在前列腺癌中,DSCAM-AS1被显著上调.
- DSCAM-AS1通过准miR-338-3p.p.来促进前列腺癌的进展.
- DSCAM-AS1代表了前列腺癌的潜在诊断生物标志物和治疗点.
更多相关视频
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
相关概念视频
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Prevention
Some...
Cancer Prevention
Some...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...